Livzon Pharmaceutical Group Inc. (01513.HK / 000513.SZ) Releases Next Day Disclosure Return with Unchanged Share Capital and Continued A-Share Buybacks

Bulletin Express

2025/11/05

Livzon Pharmaceutical Group Inc. reported no changes in the total number of issued H shares at 299,807,117 and no changes in the total number of issued A shares at 604,293,313 as of November 5, 2025. According to the announcement, both figures remained the same as on November 4, showing no new issuance or cancellation activity for that period.

The filing also detailed an ongoing A-share repurchase program on the Shenzhen Stock Exchange. Shares repurchased on various dates since December 2024 remain pending cancellation and have not yet been removed from the total share count. The most recent repurchase occurred on November 5, 2025, involving 164,200 A shares with a highest repurchase price of RMB 36.64, a lowest repurchase price of RMB 36.41, and an aggregate price of approximately RMB 5.999 million. All transactions have been carried out in compliance with relevant regulations, and the repurchased shares awaiting cancellation are disclosed in the announcement.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1196184338"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1196184338\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1196184338?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 19:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196184338","market":"hk","top_or_hot":-1,"title":"Livzon Pharmaceutical Group Inc. (01513.HK / 000513.SZ) Releases Next Day Disclosure Return with Unchanged Share Capital and Continued A-Share Buybacks","media":"Bulletin Express","content":"<p>Livzon Pharmaceutical Group Inc. reported no changes in the total number of issued H shares at 299,807,117 and no changes in the total number of issued A shares at 604,293,313 as of November 5, 2025. According to the announcement, both figures remained the same as on November 4, showing no new issuance or cancellation activity for that period.</p>\n<p>The filing also detailed an ongoing A-share repurchase program on the Shenzhen Stock Exchange. Shares repurchased on various dates since December 2024 remain pending cancellation and have not yet been removed from the total share count. The most recent repurchase occurred on November 5, 2025, involving 164,200 A shares with a highest repurchase price of RMB 36.64, a lowest repurchase price of RMB 36.41, and an aggregate price of approximately RMB 5.999 million. All transactions have been carried out in compliance with relevant regulations, and the repurchased shares awaiting cancellation are disclosed in the announcement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharmaceutical Group Inc. (01513.HK / 000513.SZ) Releases Next Day Disclosure Return with Unchanged Share Capital and Continued A-Share Buybacks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharmaceutical Group Inc. (01513.HK / 000513.SZ) Releases Next Day Disclosure Return with Unchanged Share Capital and Continued A-Share Buybacks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-05 19:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Livzon Pharmaceutical Group Inc. reported no changes in the total number of issued H shares at 299,807,117 and no changes in the total number of issued A shares at 604,293,313 as of November 5, 2025. According to the announcement, both figures remained the same as on November 4, showing no new issuance or cancellation activity for that period.</p>\n<p>The filing also detailed an ongoing A-share repurchase program on the Shenzhen Stock Exchange. Shares repurchased on various dates since December 2024 remain pending cancellation and have not yet been removed from the total share count. The most recent repurchase occurred on November 5, 2025, involving 164,200 A shares with a highest repurchase price of RMB 36.64, a lowest repurchase price of RMB 36.41, and an aggregate price of approximately RMB 5.999 million. All transactions have been carried out in compliance with relevant regulations, and the repurchased shares awaiting cancellation are disclosed in the announcement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"丽珠医药","start_time":0,"source_url":"","article_id":"1196184338","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196184338","pubTimestamp":1762341834,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Livzon Pharmaceutical Group Inc. reported no changes in the total number of issued H shares at 299,807,117 and no changes in the total number of issued A shares at 604,293,313 as of November 5, 2025....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药集团股份有限公司(01513.HK/000513.SZ)发布翌日披露报表股本不变继续A股回购","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"Livzon Pharmaceutical Group Inc. reported no changes in the total number of issued H shares at 299,807,117 and no changes in the total number of issued A shares at 604,293,313 as of November 5, 2025. According to the announcement, both figures remained the same as on November 4, showing no new issuance or cancellation activity for that period.\nThe filing also detailed an ongoing A-share repurchase program on the Shenzhen Stock Exchange. Shares repurchased on various dates since December 2024 remain pending cancellation and have not yet been removed from the total share count. The most recent repurchase occurred on November 5, 2025, involving 164,200 A shares with a highest repurchase price of RMB 36.64, a lowest repurchase price of RMB 36.41, and an aggregate price of approximately RMB 5.999 million. All transactions have been carried out in compliance with relevant regulations, and the repurchased shares awaiting cancellation are disclosed in the announcement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}